Skip to main content
Friday
January 31, 2025
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
JANUARY 31, 2025
GSK
World+Biz
GSK licenses companies to make cheap copies of HIV prevention drug
World+Biz
Unilever CEO set to leave after GSK debacle, arrival of activist investor
Coronavirus chronicle
Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
Global Economy
Unilever's offer for GSK's consumer health raises doubts, questions over strategy
Global Economy
Unilever says it wants to buy GSK's consumer goods arm
Coronavirus chronicle
New data shows GSK-Vir drug works against all Omicron mutations
Coronavirus chronicle
UK approves GSK Covid drug, appears effective against Omicron
Coronavirus chronicle
GSK says tests show antibody drug works against Omicron
Health
GSK to develop longer-acting therapy for HIV with Japan's Shionogi
Coronavirus chronicle
Study confirms GSK-Vir antibody drug reduces hospitalisation, death in Covid-19 patients
World+Biz
GSK fires former US govt vaccine head Slaoui over harassment allegation
Coronavirus chronicle
GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine
Coronavirus chronicle
GSK, Vir Biotech to expand Covid -19 research partnership for other diseases
Show More